PPI-368

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePPI-368
Drug Alias NamePPI-368
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPraecis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPraecis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A